More on ALXO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+68.3% Growth)
- Ratings (8.8 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ALX Oncology (NQ:ALXO)
Delayed: 1.17 -0.02 (1.68%)
Prev. Close $1.19  
Open$1.17 
52 Wk High$ 
52 Wk Low$ 
Day High$1.23 
Day Low$1.10 
P/E N/A  
EPS$ 
Volume556,402 

Friends, Peers and Foes (?): ERAS, IMRX, ONCY PRLD (more...)

Oct 16, 2026 09:21 PM Form SCHEDULE 13D/A ALX ONCOLOGY HOLDINGS Filed by: venBio Global Strategic Fund, L.P.
Oct 15, 2026 04:56 PM Form 8-K ALX ONCOLOGY HOLDINGS For: Oct 14
Sep 28, 2026 08:01 AM ALX Oncology publishes Phase 2 gastric cancer trial data in Nature Medicine
Sep 28, 2026 08:00 AM ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
Sep 2, 2026 08:00 AM ALX Oncology to Present at Upcoming Investor Conferences in September
Aug 18, 2026 05:51 PM Form 4 ALX ONCOLOGY HOLDINGS For: Aug 17 Filed by: Lettmann Jason
Aug 18, 2026 05:50 PM Form 4 ALX ONCOLOGY HOLDINGS For: Aug 17 Filed by: Wong Shelly
Aug 14, 2026 04:31 PM Form SCHEDULE 13G/A ALX ONCOLOGY HOLDINGS Filed by: TCG Crossover GP II, LLC
Aug 6, 2026 04:02 PM Form 10-Q ALX ONCOLOGY HOLDINGS For: Jun 30
Aug 6, 2026 08:34 AM ALX Oncology Holdings Inc. (ALXO) Tops Q2 EPS by 4c
View All Articles

Entities mentioned with ALXO

View All Entities